The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced substantial uncertainty . Investors are now grappling with the effect o